Home
About
Overview
Sharing Data
ORCID
Help
History (20)
Specific inhibition of MyD88-independent signaling pathways of TLR3 and TLR4 by resveratrol: molecular targets are TBK1 and RIP1 in TRIF complex.
Results of an early access treatment protocol of daratumumab in United States patients with relapsed or refractory multiple myeloma.
Synonymous Mutations at the Beginning of the Influenza A Virus Hemagglutinin Gene Impact Experimental Fitness.
Amino Acid Isomerases
Is surgical myectomy challenged by emergence of novel drug therapy with mavacamten?
See All 20 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Is surgical myectomy challenged by emergence of novel drug therapy with mavacamten?
Maron MS, Rowin EJ, Maron BJ. Is surgical myectomy challenged by emergence of novel drug therapy with mavacamten? Asian Cardiovasc Thorac Ann. 2022 Jan; 30(1):11-18.
View in:
PubMed
subject areas
Benzylamines
Cardiomyopathy, Hypertrophic
Humans
Treatment Outcome
Uracil
authors with profiles
Martin S Maron MD, MSPH
Barry J Maron MD
Ethan Rowin MD, MBA